23.51
price up icon0.21%   0.05
after-market Dopo l'orario di chiusura: 23.40 -0.11 -0.47%
loading
Precedente Chiudi:
$23.46
Aprire:
$23.49
Volume 24 ore:
146.58K
Relative Volume:
0.51
Capitalizzazione di mercato:
$1.64B
Reddito:
$26.98M
Utile/perdita netta:
$-180.66M
Rapporto P/E:
-5.0235
EPS:
-4.68
Flusso di cassa netto:
$-63.56M
1 W Prestazione:
-3.92%
1M Prestazione:
-0.38%
6M Prestazione:
-4.35%
1 anno Prestazione:
+51.38%
Intervallo 1D:
Value
$23.25
$23.99
Intervallo di 1 settimana:
Value
$22.54
$24.96
Portata 52W:
Value
$12.54
$28.67

Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile

Name
Nome
Bicycle Therapeutics Plc Adr
Name
Telefono
011441223261503
Name
Indirizzo
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE
Name
Dipendente
284
Name
Cinguettio
@Bicycle_tx
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
BCYC's Discussions on Twitter

Bicycle Therapeutics Plc Adr Stock (BCYC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-09-11 Aggiornamento B. Riley Securities Neutral → Buy
2022-08-31 Iniziato Cowen Outperform
2022-07-28 Iniziato Barclays Overweight
2022-07-06 Ripresa Canaccord Genuity Buy
2022-04-13 Downgrade B. Riley Securities Buy → Neutral
2022-04-07 Ripresa Cantor Fitzgerald Overweight
2022-02-14 Iniziato Morgan Stanley Equal-Weight
2021-12-17 Iniziato SVB Leerink Outperform
2021-12-09 Iniziato Needham Buy
2021-09-30 Iniziato B. Riley Securities Buy
2021-04-20 Iniziato JMP Securities Mkt Outperform
2020-10-12 Iniziato Cantor Fitzgerald Overweight
2020-06-12 Iniziato Oppenheimer Outperform
2020-04-17 Iniziato H.C. Wainwright Buy
2019-11-14 Iniziato ROTH Capital Buy
2019-09-11 Aggiornamento Goldman Neutral → Buy
2019-06-17 Iniziato Canaccord Genuity Buy
2019-06-17 Iniziato Goldman Neutral
2019-06-17 Iniziato Jefferies Buy
2019-06-17 Iniziato Piper Jaffray Overweight
Mostra tutto

Bicycle Therapeutics Plc Adr Borsa (BCYC) Ultime notizie

pulisher
Oct 28, 2024

Bicycle Therapeutics' SWOT analysis: stock's potential rides on innovative platform - Investing.com India

Oct 28, 2024
pulisher
Oct 23, 2024

Bicycle Therapeutics spotlights cancer treatment targets - Investing.com

Oct 23, 2024
pulisher
Oct 19, 2024

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - MSN

Oct 19, 2024
pulisher
Oct 14, 2024

A company insider recently sold 3,212 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Oct 14, 2024
pulisher
Oct 10, 2024

BCYC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Oct 10, 2024
pulisher
Oct 08, 2024

Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Bicycle Therapeutics Plc ADR (BCYC)’s stock price range in the last year - US Post News

Oct 08, 2024
pulisher
Oct 05, 2024

Bicycle therapeutics executive sells shares worth over $21k - Investing.com India

Oct 05, 2024
pulisher
Oct 05, 2024

Bicycle therapeutics executive sells shares to cover tax obligations - Investing.com India

Oct 05, 2024
pulisher
Oct 04, 2024

Bicycle therapeutics COO sells shares worth over $21k - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

Bicycle therapeutics CEO sells shares worth over $71k - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Bicycle therapeutics CTO sells shares worth over $21k - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Bicycle therapeutics executive sells shares worth over $5,000 - Investing.com

Oct 04, 2024
pulisher
Oct 03, 2024

CHIEF PROD & SUPPLY CHAIN OFF Hannay Michael Charles Ferguso sale 246 shares of Bicycle Therapeutics Plc ADR [BCYC] – Knox Daily - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

Bicycle Therapeutics Plc ADR (BCYC)’s stock chart: A technical perspective - US Post News

Oct 03, 2024
pulisher
Oct 03, 2024

Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 22.56 - The Dwinnex

Oct 03, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Bicycle Therapeutics stock rides high on cancer drug promise - Investing.com

Sep 27, 2024
pulisher
Sep 20, 2024

A company insider recently sold 246 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You Sale? - Knox Daily

Sep 20, 2024
pulisher
Sep 19, 2024

Nothing is Better Than Bicycle Therapeutics Plc ADR (BCYC) stock at the moment - SETE News

Sep 19, 2024
pulisher
Sep 17, 2024

RBC Capital Mkts initates Bicycle Therapeutics Plc ADR (BCYC) stock to an Outperform - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Metric Analysis: Bicycle Therapeutics Plc ADR (BCYC)’s Key Ratios in the Limelight - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

Bicycle Therapeutics Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle

Sep 17, 2024
pulisher
Sep 17, 2024

Are Bicycle Therapeutics Plc ADR (BCYC) shares a good deal now? - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Hain Celestial Group Inc [HAIN] Investment Guide: What You Need to Know - Knox Daily

Sep 17, 2024
pulisher
Sep 16, 2024

Bicycle Therapeutics stock maintains Buy rating post-ESMO data By Investing.com - Investing.com UK

Sep 16, 2024
pulisher
Sep 12, 2024

Bicycle Therapeutics Plc ADR [BCYC] Shares Fall -0.26 % on Wednesday - Knox Daily

Sep 12, 2024
pulisher
Sep 12, 2024

A stock that deserves closer examination: Bicycle Therapeutics Plc ADR (BCYC) - US Post News

Sep 12, 2024
pulisher
Sep 10, 2024

Bicycle Therapeutics Plc ADR (BCYC) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle

Sep 10, 2024
pulisher
Sep 05, 2024

Aqua Metals Inc [AQMS] Shares Fall Approximately -81.89% Over the Year - Knox Daily

Sep 05, 2024
pulisher
Sep 05, 2024

Taking a look at what insiders are doing to gauge the Interface Inc. [TILE] - Knox Daily

Sep 05, 2024
pulisher
Sep 05, 2024

Sleep Number Corp [SNBR] Director makes an insider purchase of 43,000 shares worth 0.53 million. - Knox Daily

Sep 05, 2024
pulisher
Sep 02, 2024

Top investors say Bicycle Therapeutics Plc ADR (BCYC) ticks everything they need - SETE News

Sep 02, 2024
pulisher
Aug 31, 2024

Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade - MSN

Aug 31, 2024
pulisher
Aug 28, 2024

An Analysis of Bicycle Therapeutics Plc ADR (BCYC)’s Potential Price Growth - Knox Daily

Aug 28, 2024
pulisher
Aug 13, 2024

CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 - MSN

Aug 13, 2024
pulisher
Aug 09, 2024

What Makes Bicycle Therapeutics (BCYC) a New Buy Stock - Yahoo Finance

Aug 09, 2024
pulisher
Aug 09, 2024

Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High? - Yahoo Finance

Aug 09, 2024
pulisher
Aug 05, 2024

B. Riley Securities’s latest rating for BCYC stock - Knox Daily

Aug 05, 2024
pulisher
Jul 31, 2024

Bicycle Therapeutics Plc ADR (BCYC) may enjoy gains as insiders got busy in the recent days - Knox Daily

Jul 31, 2024
pulisher
Jul 24, 2024

Bicycle Therapeutics Plc ADR’s latest rating changes from various analysts - Knox Daily

Jul 24, 2024
pulisher
Jul 03, 2024

Bicycle Therapeutics Plc ADR [BCYC] Investment Appeal on the Rise – Knox Daily - Knox Daily

Jul 03, 2024
pulisher
Jul 03, 2024

Is it a good time to sell Wendy's Co [WEN] shares after an insider sold 21000 shares? – Knox Daily - Knox Daily

Jul 03, 2024
pulisher
Jun 30, 2024

Strength Seen in Bicycle Therapeutics PLC Sponsored ADR (BCYC): Can Its 5.9% Jump Turn into More Strength? - Yahoo Movies UK

Jun 30, 2024
pulisher
Jun 29, 2024

Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up - Yahoo News Malaysia

Jun 29, 2024
pulisher
Jun 28, 2024

Bicycle Therapeutics PLC Sponsored ADR (BCYC) Soars 19.3%: Is Further Upside Left in the Stock? - Yahoo Sport Australia

Jun 28, 2024
pulisher
Jun 27, 2024

Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year? - Yahoo Finance

Jun 27, 2024
pulisher
Jun 26, 2024

Investing in Bicycle Therapeutics Plc ADR (BCYC) Is Getting More Attractive – Knox Daily - Knox Daily

Jun 26, 2024
pulisher
Jun 21, 2024

Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research

Jun 21, 2024
pulisher
Jun 21, 2024

Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research

Jun 21, 2024
pulisher
Jun 19, 2024

Trading Day Review: Bicycle Therapeutics Plc ADR (BCYC) Loses Momentum, Closing at 20.75 – DWinneX - The Dwinnex

Jun 19, 2024
pulisher
Jun 19, 2024

BCYC Stock on the Rise: A Promising Investment - The InvestChronicle

Jun 19, 2024

Bicycle Therapeutics Plc Adr Azioni (BCYC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):